Core Points - Sharps Technology, Inc. will implement a 1-for-300 reverse stock split effective April 27, 2025, to comply with Nasdaq's minimum bid price requirement [1][2] - The reverse split will reduce the authorized common shares from 500,000,000 to 1,666,667, and it was approved by the Board without shareholder consent [3] Company Overview - Sharps Technology is a medical device and pharmaceutical packaging company that specializes in patented smart-safety syringe products aimed at the healthcare industry [4] - The company focuses on ultra-low waste capabilities and incorporates both passive and active safety features in its syringe technologies [4] - Sharps also produces products designed with specialized copolymer technology for the prefillable syringe market segment and operates a manufacturing facility in Hungary [4]
Sharps Technology Announces Reverse Stock Split